Articles
FDA warnings - Sub Categories
Parents Caught in the Middle as FDA Committee Debates
FDA Hearings on Ritalin: Black Box Labeling Recommendation for ADHD Medications in Debate
On February 9, 2006, the FDA’s standing Drug Safety and Risk Management Advisory Committee was tasked for the morning to study ADHD medications to see if there was a link between the stimulant medications and an increased risk of sudden death or serious cardiovascular problems from taking the medications.
The FDA also tasked the Committed with considering ways of studying the drugs without putting patients at risk. Read more of the article...
FDA Black Box Warning Labels on ADHD Medications
After much debate the following medications carry the "black box warnings" on the labels of the bottles. These are the strongest warnings that the FDA requires, a step away from pulling the medications. Read more of the article...
